<< Back
Valeant Pharmaceuticals To Host Investor Day

MONTREAL, June 7, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International (NYSE:VRX) (TSX: VRX) today announced that it will host an Investor Day in Florham Park, New Jersey, on Thursday, June 21, 2012 from 8:30 a.m. to 12:30 p.m. ET.  J. Michael Pearson, Valeant's chairman and chief executive officer, and other members of Valeant's management team will discuss the company's strategies and opportunities in each of its business regions.

A live video webcast and slide presentation of the event will be available on the company's web site at www.valeant.com. To access the webcast select "Investor Relations" and find the event listed under "Events and Presentations."  Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen and view to the Internet webcast. The webcast will be archived on the company's website for future on-demand replay.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

SOURCE Valeant Pharmaceuticals International, Inc.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Valeant Pharmaceuticals International, Inc.'s business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report or Form 10-K for the most recently ended fiscal year.